← Eichor
Study identifier: NCT05217810 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®

Condition: Asthma  ·  Sponsor: Novartis Pharmaceuticals

PhaseN/A
Planned participants600
Who can joinAll sexes, 12 Years to 100 Years
Healthy volunteersNo

About this study

This surveillance was designed as a prospective, open-label, multicenter, single-arm, non-interventional, observational study to evaluate the safety and effectiveness of Atectura inhalation capsule for up to 24 weeks under routine clinical practice.

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals  ·  +41613241111  ·  novartis.email@novartis.com

Novartis Pharmaceuticals

Always discuss trial participation with your own doctor first.

Locations (18)

Novartis Investigative SiteDaegu, Dalseo gu, South KoreaRecruiting
Novartis Investigative SiteKangwon Do, Gangneung si, South KoreaCompleted
Novartis Investigative SiteWŏnju, Gangwon-do, South KoreaActive Not Recruiting
Novartis Investigative SiteGoyang-si, Gyeonggi-do, South KoreaRecruiting
Novartis Investigative SiteGuri-si, Gyeonggi-do, South KoreaCompleted
Novartis Investigative SiteJeonju, Jeollabuk-do, South KoreaRecruiting
Novartis Investigative SiteIksan Si, Jeonlabuk Do, South KoreaRecruiting
Novartis Investigative SiteDaejeon, Korea, South KoreaCompleted
Novartis Investigative SiteBusan, South KoreaRecruiting
Novartis Investigative SiteGyeongsangnam Do, South KoreaCompleted
Novartis Investigative SiteJeju City, South KoreaRecruiting
Novartis Investigative SiteJinju, South KoreaRecruiting

+ 6 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05217810